Creative Medical Technology Holdings Inc (CELZ)
4.42
+0.08
(+1.84%)
USD |
NASDAQ |
May 17, 16:00
4.42
0.00 (0.00%)
After-Hours: 16:09
Creative Medical Technology Holdings Cash from Financing (Quarterly): -0.0828M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.0828M |
| December 31, 2023 | -0.271M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 15.47M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 9.307M |
| September 30, 2021 | 2.810M |
| June 30, 2021 | 0.1056M |
| March 31, 2021 | 0.6186M |
| December 31, 2020 | 0.2523M |
| September 30, 2020 | 0.1757M |
| June 30, 2020 | 0.1209M |
| March 31, 2020 | 0.145M |
| December 31, 2019 | 0.1828M |
| September 30, 2019 | 0.3124M |
| June 30, 2019 | 0.114M |
| March 31, 2019 | 0.3884M |
| December 31, 2018 | 0.4269M |
| September 30, 2018 | 0.4193M |
| June 30, 2018 | 0.243M |
| March 31, 2018 | 0.2535M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.1152M |
| September 30, 2017 | 0.0905M |
| June 30, 2017 | 0.3757M |
| March 31, 2017 | 0.10M |
| December 31, 2016 | 0.3738M |
| September 30, 2016 | 0.1386M |
| June 30, 2016 | 0.1139M |
| March 31, 2016 | 0.0507M |
| December 31, 2015 | 0.0014M |
| September 30, 2015 | 0.0025M |
| June 30, 2015 | 0.005M |
| March 31, 2015 | 0.005M |
| December 31, 2014 | 0.005M |
| September 30, 2014 | 0.0027M |
| June 30, 2014 | 0.0053M |
| March 31, 2014 | 0.005M |
| December 31, 2013 | 0.0043M |
| September 30, 2013 | 0.0037M |
| June 30, 2013 | 0.0057M |
| March 31, 2013 | 0.0089M |
| December 31, 2012 | 0.0032M |
| September 30, 2012 | 0.0042M |
| June 30, 2012 | 0.0025M |
| March 31, 2012 | 0.0065M |
| December 31, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.271M
Minimum
Dec 2023
15.47M
Maximum
Jun 2022
1.463M
Average
0.1174M
Median
Cash from Financing (Quarterly) Benchmarks
| Avid Bioservices Inc | 0.085M |
| Viking Therapeutics Inc | 606.04M |
| Avinger Inc | -0.061M |
| Aptevo Therapeutics Inc | -0.003M |
| Absci Corp | 81.18M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8969M |
| Cash from Investing (Quarterly) | 6.520M |
| Free Cash Flow | -5.083M |
| Free Cash Flow Per Share (Quarterly) | -0.631 |
| Free Cash Flow Yield | -81.50% |